<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04336228</url>
  </required_header>
  <id_info>
    <org_study_id>H-18038325</org_study_id>
    <nct_id>NCT04336228</nct_id>
  </id_info>
  <brief_title>The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms</brief_title>
  <official_title>The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Cambridge</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lundbeck Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this project is to investigate:

        -  The status of the central serotonin (5-hydroxytryptamine, 5-HT) system in compulsive
           behaviour and how it is affected by sub-chronic escitalopram administration

        -  The mechanisms underlying how sub-chronic administration of escitalopram affects the
           central 5-HT system

        -  How changes in cognitive performance, including the balance between habitual and
           goal-directed mechanisms, are affected in compulsive behaviour by boosting 5-HT function

        -  How functional brain changes in cognitive function measured with magnetic resonance
           imaging relate to altered 5-HT function following escitalopram administration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous studies have shown that 5-HT is strongly implicated in compulsive behaviours in
      experimental animals. Manipulation of 5-HT influences neuronal interactions underlying action
      selection. Reduced forebrain 5-HT causes perseveration and impairs goal-directed behaviour
      under reward but not punishment. Dysfunctional 5-HT neurotransmission has also been
      implicated in Obsessive-Compulsive Disorder (OCD) based on the selective efficacy of
      relatively high doses of selective serotonin reuptake inhibitors (SSRIs) in treating this
      disorder. Hitherto, it is unknown whether there is a primary defect in the serotonergic
      system or whether SSRIs ameliorate symptoms by modulating other brain neurotransmitter
      pathways. So far, only one study of central 5-HT release in OCD patients has been conducted
      and its methodology may be questioned.

      A number of behavioural and cognitive features of OCD, including endophenotype markers that
      appear to characterise the disorder have been determined. These include a shift in cognitive
      control from a goal-directed strategy to a habitual (stimulus-response, S-R) strategy,
      cognitive rigidity in terms of both reversal learning and attentional set-shifting, impaired
      response inhibition and planning, and a tendency to over-respond to spurious negative
      feedback in a probabilistic learning paradigm. Neural substrates of these deficits are being
      investigated using brain imaging methodologies based on magnetic resonance and preliminary
      evidence suggests an over-active medial prefrontal cortex-caudate nucleus circuits and
      underactive lateral prefrontal cortex-putamen circuits. However, little evidence exists that
      relates to the hypothesis of an over-active habit system in this disorder or to the role of
      serotonin in all these cognitive and behavioural deficits observed in OCD and compulsivity in
      general.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2020</start_date>
  <completion_date type="Anticipated">August 2024</completion_date>
  <primary_completion_date type="Anticipated">August 2024</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Learning Primary Outcome 1 measured with Probability Reversal Learning test: Mean errors Stage 1 (Learning)</measure>
    <time_frame>3 years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Learning Primary Outcome 2 measured with Probability Reversal Learning test: Mean errors Stage 2 (Reversal)</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Learning Primary Outcome 3 measured with Deterministic Reversal Learning test: Percent correct per stage</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inhibition Primary Outcome 1 measured with Interleaved Stop Signal Task/Go-NoGo: Stop Signal Reaction Time</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Flexibility Primary Outcome 1 measured with 3Dimensional Intra/Extra Dimensional Shift test: Extra Dimensional Set Errors</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Flexibility Primary Outcome 2 measured with Sequential model-based model-free test: Model-based Model-free Weight</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social Cognition Primary Outcome 1 measured with EMOTICOM Moral Emotions Task: Agent Guilt Score</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social Cognition Primary Outcome 2 measured with EMOTICOM Moral Emotions Task: Agent Shame Score</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. The false discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotion Recognition Primary Outcome 1 measures with EMOTICOM Intensity Morphing: Affective bias in decreasing condition</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotion Recognition Primary Outcome 2 measured with EMOTICOM Emotion Recognition Task: Affective bias for D'</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotion Recognition Primary Outcome 3 measured with EMOTICOM Intensity Morphing task: Detection threshold decreasing</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotion Recognition Primary Outcome 4 measured with EMOTICOM Emotion Recognition task: D'Prime for emotion recognition</measure>
    <time_frame>3 Years</time_frame>
    <description>Emotion Recognition Task. Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Memory Primary Outcome 1 measured with CANTAB Paired Associates Learning: Total Errors Adj</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biofluids</measure>
    <time_frame>3 Years</time_frame>
    <description>Serum Escitalopram levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positron emission tomography (PET) Imaging: Cerebral [11C]SB207145 PET binding.</measure>
    <time_frame>3 Years</time_frame>
    <description>Collected before and after participant's intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Slip of Actions</measure>
    <time_frame>3 Years</time_frame>
    <description>Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Cohabit</measure>
    <time_frame>3 Years</time_frame>
    <description>Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12Co-habit fMRI paradigm Imaging outcomes will be FWE corrected using Random Field Theory as implemented in SPM12.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Faces</measure>
    <time_frame>3 Years</time_frame>
    <description>Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resting State fMRI</measure>
    <time_frame>3 Years</time_frame>
    <description>Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Structural Voxel-based morphometry (VBM) MRI</measure>
    <time_frame>3 Years</time_frame>
    <description>Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diffusion Tensor Imaging MRI</measure>
    <time_frame>3 Years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Habit formation outcome 1: response times for each day of training</measure>
    <time_frame>3 Years</time_frame>
    <description>Daily app training paradigm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Habit formation outcome 2: mean errors per sequence and moves</measure>
    <time_frame>3 Years</time_frame>
    <description>Daily app training paradigm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Habit formation outcome 3: confidence and enjoyable rates.</measure>
    <time_frame>3 Years</time_frame>
    <description>Daily app training paradigm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Learning Secondary Outcome 1 measured with Probability Reversal Learning test: Stage 1 Reward-Stay/Lose-Shift behaviour</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Learning Secondary Outcome 2 measured with Probability Reversal Learning test: Stage 1 Reward/Punishment learning</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Learning Secondary Outcome 3 measured with Probability Reversal Learning test: Stage 1. Stimulus Stickiness</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Learning Secondary Outcome 4 measured with Probability Reversal Learning test: Stage 2 Reward-Stay/ Lose-Shift behaviour</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Learning Secondary Outcome 5 measured with Probability Reversal Learning test: Stage 2 Reward/Punishment learning</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Learning Secondary Outcome 6 measured with Probability Reversal Learning test: Stage 2. Stimulus Stickiness</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Learning Secondary Outcome 7 measured with Deterministic Reversal Learning test: Reward-Stay/ Lose-Shift behaviour</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flexibility Secondary Outcome 1 measured with Sequential Model-Based/Model-Free test: Proportion of Stays</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flexibility Secondary Outcome 2 measured with Sequential Model-Based/Model-Free test: Exploration</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flexibility Secondary Outcome 3 measured with Sequential Model-Based/Model-Free test: Stimulus Stickiness</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flexibility Secondary Outcome 4 measured with Sequential Model-Based/Model-Free test: Learning rate</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flexibility Secondary Outcome 5 measured with 3Dimensional Intra/Extra Dimensional Shift test: Pre Extra Dimension Set Errors</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flexibility Secondary Outcome 6 measured with 3Dimensional Intra/Extra Dimensional Shift test: Latency</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inhibition Secondary Outcome 1 measured with Interleaved Stop Signal Task/Go-NoGo: Go reaction time</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inhibition Secondary Outcome 2 measured with Interleaved Stop Signal Task/Go-NoGo: Go omission error rate</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inhibition Secondary Outcome 3 measured with Interleaved Stop Signal Task/Go-NoGo: Go commission error rate</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inhibition Secondary Outcome 4 measured with Interleaved Stop Signal Task/Go-NoGo: No-Go error rate</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Executive Function Secondary Outcome 1 measured with 3Dimensional Intra/Extra Dimensional Shift test: Total Errors Adjusted</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emotion Recognition Secondary Outcome 1 measured with EMOTICOM Intensity Morphing Task: Detection threshold increasing</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emotion Recognition Secondary Outcome 2 measured with EMOTICOM Intensity Morphing Task: Affective bias in increasing condition</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emotion Recognition Secondary Outcome 3 measured with EMOTICOM Emotion Recognition Task: Affective bias for Hit Rate</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emotion Recognition Secondary Outcome 4 measured with EMOTICOM Emotion Recognition Task.: Hit Rate for Emotion Recognition</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Faces and geometric figure discrimination Outcome 1 measured with fMRI faces paradigm: Accuracy</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioural outcomes with Faces and geometric figure discrimination Outcome 2 measured with fMRI faces paradigm: Response Speed</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioural outcomes with fMRI paradigm slip of Actions : accuracy and latency</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioural outcomes with fMRI paradigm Co-habit: accuracy and latency.</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Memory Outcome 1 measured with CANTAB Paired Associates Learning test: First Trial Memory Score</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Memory Outcome 2 measured with Letter-number sequencing test: Total score</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Memory Primary outcome 3 measured with Verbal Affective Memory Test-26: Latent variable model of the association between positive, negative and neutral word recall and 5-HT4R binding</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risky Decision Making Outcome Outcome 1 measured with EMOTICOM Cambridge Gamble Task: Quality of Decision Making</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risky Decision Making Outcome 2 measured with EMOTICOM Cambridge Gamble Task: Risk Adjustment</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risky Decision Making Outcome 3 measured with EMOTICOM Cambridge Gamble Task: Overall Proportion Bet</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risky Decision Making Outcome 4 measured with EMOTICOM Cambridge Gamble Task: Deliberation Time</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychomotor Speed Outcome 1 measured with CANTAB Reaction Time Task: Simple reaction time</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intelligence Quotient (IQ) outcome 1 measured with Reynolds Intellectual assessment Scales subtest &quot;guess what&quot; and &quot;what does not fit&quot;: Total age adjusted score</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interpersonal Reactivity Index (IRI) Score</measure>
    <time_frame>3 Years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obsessive- Compulsive Inventory (OCI)- state Score</measure>
    <time_frame>3 Years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obsessive- Compulsive Inventory- trait Score</measure>
    <time_frame>3 Years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brief Symptom Inventory (BSI) Score</measure>
    <time_frame>3 Years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh Sleep Quality Index Score</measure>
    <time_frame>3 Years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Profile of Mood State Score</measure>
    <time_frame>3 Years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory-II Score</measure>
    <time_frame>3 Years</time_frame>
    <description>Contain 21-items, scored on a scale value of 0 to 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory Scale Score</measure>
    <time_frame>3 Years</time_frame>
    <description>Contain 40-items</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State and Trait Aggression Questionnaire Score</measure>
    <time_frame>3 Years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barratt Impulsiveness Scale-State Score</measure>
    <time_frame>3 Years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale Score</measure>
    <time_frame>3 Years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Emotion Recognition Other Outcome 1: Detection threshold decreasing Happy - Intensity Morphing</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains.</description>
  </other_outcome>
  <other_outcome>
    <measure>Emotion Recognition Other Outcome 2: Detection threshold decreasing Sad - Intensity Morphing</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains.</description>
  </other_outcome>
  <other_outcome>
    <measure>Emotion Recognition Other Outcome 3: Detection threshold decreasing Anger - Intensity Morphing</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains.</description>
  </other_outcome>
  <other_outcome>
    <measure>Emotion Recognition Other Outcome 4: Detection threshold decreasing Fear - Intensity Morphing</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains.</description>
  </other_outcome>
  <other_outcome>
    <measure>Emotion Recognition Other Outcome 5: Detection threshold decreasing Disgust - Intensity Morphing</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains.</description>
  </other_outcome>
  <other_outcome>
    <measure>Emotion Recognition Other Outcome 6: D' Happy - Emotion Recognition Task</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains.</description>
  </other_outcome>
  <other_outcome>
    <measure>Emotion Recognition Other Outcome 7: D' Sad - Emotion Recognition Task</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains.</description>
  </other_outcome>
  <other_outcome>
    <measure>Emotion Recognition Other Outcome 8: D' Fear - Emotion Recognition Task</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains.</description>
  </other_outcome>
  <other_outcome>
    <measure>Emotion Recognition Other Outcome 9: D' Anger - Emotion Recognition Task</measure>
    <time_frame>3 Years</time_frame>
    <description>Outcome variables have been grouped a priori into carefully defined cognitive domains.</description>
  </other_outcome>
  <other_outcome>
    <measure>Activity Level Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Behavioural Inhibition/ Behavioural Avoidance Scale Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Compulsive Personality Assessment Scale Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Sexuality Questionnaire Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Edinburgh Handedness Inventory Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Revised NEO Personality Questionnaire Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Family History Assessment Module Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Positive Life Events Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Stressful Life Events Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Perceived stress scale</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Barratt Impulsiveness Scale-Trait Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Penn State Worry Questionnaire- Trait Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Penn State Worry Questionnaire- State Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Self-Control Scale- Trait Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Self-Control Scale- State Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>State- Trait Anxiety Inventory- Trait Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Warwick-Edinburgh Mental Well-being Scale -State Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Warwick-Edinburgh Mental Well-being Scale -Trait Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Mindful Attention and Awareness Scale -State Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Mindful Attention and Awareness Scale -Trait Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Intolerance of Uncertainty Scale - Trait Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Intolerance of Uncertainty Scale - State Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Verran and Snyder-Halpern (VSH) Sleep Scale Score</measure>
    <time_frame>3 Years</time_frame>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Obsessive-Compulsive Disorder</condition>
  <condition>Healthy Individuals</condition>
  <arm_group>
    <arm_group_label>Healthy Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The healthy placebo control group will be administered the exact same procedure as the intervention group, the only difference being that this group will be administered a placebo tablet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obsessive-Compulsive Disorder Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The OCD placebo control group will be administered the exact same procedure as the intervention group, the only difference being that this group will be administered a placebo tablet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The healthy intervention group will be administered 20mg of Escitalopram daily for 3-4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obsessive-Compulsive Disorder Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The healthy intervention group will be administered 20mg of Escitalopram daily for 3-4 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Escitalopram</intervention_name>
    <description>20mg daily for 3-4 weeks.</description>
    <arm_group_label>Healthy Intervention Group</arm_group_label>
    <arm_group_label>Obsessive-Compulsive Disorder Intervention Group</arm_group_label>
    <other_name>Escitalopram STADA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo oral tablet</intervention_name>
    <description>20mg placebo tablet daily for 3-4 weeks.</description>
    <arm_group_label>Healthy Control Group</arm_group_label>
    <arm_group_label>Obsessive-Compulsive Disorder Control Group</arm_group_label>
    <other_name>calcium tables</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  OCD patients and healthy volunteers (male or female) between 18 and 70 years.

        Exclusion Criteria:

          -  Current or previous neurological disease, severe somatic disease, or consumption of
             medical drugs likely to influence the test results

          -  Non- fluent in Danish or pronounced visual or auditory impairments

          -  Current or past learning disability.

          -  Pregnancy (females).

          -  Lactation (females).

          -  Participation in experiments with radioactivity (&gt; 10 mSv) within the last year or
             significant occupational exposure to radioactivity.

          -  Contraindications for MRI (pacemaker, metal implants, etc.).

          -  Allergy to the ingredients in the administered drug.

          -  Abnormal ECG (e.g. prolonged QT syndrome).

          -  Dizzy when changing from supine to upright position (e.g. postural orthostatic
             tachycardia syndrome).

          -  Mild hypotension (blood pressure below 100/70 mmHg) or hypertension (blood pressure
             above 140/90 mmHg).

          -  Head injury or concussion resulting in loss of consciousness for more than 2 min.

          -  Alcohol or drug abuse

          -  Drug use other than tobacco and alcohol within the last 30 days.

          -  Hash &gt; 50 x lifetime.

          -  Drugs &gt; 10 x lifetime (for each substance).

          -  Current medication with serotonergic acting compounds. Use of other psychoactive
             substances must be stable at least one month prior to inclusion and maintained
             throughout the study.

          -  Severe physical impairments affecting eyesight or motor performance.

          -  For the OCD group: other Axis I mental disorder as primary diagnosis according to
             ICD-10 criteria.

          -  For healthy volunteers: any current or former primary psychiatric disorder (Axis I WHO
             ICD-10 diagnostic classification).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gitte M. Knudsen, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Neurobiology Research Unit, Rigshospitalet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gitte M. Knudsen, Professor</last_name>
    <phone>+45 35456720</phone>
    <email>gitte@nru.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Trevor W. Robbins, Professor</last_name>
    <phone>(01223) 333551</phone>
    <email>twr2@cam.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Neurobiology Research Unit, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC. Cognitive inflexibility after prefrontal serotonin depletion. Science. 2004 May 7;304(5672):878-80.</citation>
    <PMID>15131308</PMID>
  </reference>
  <reference>
    <citation>Dayan P, Huys QJ. Serotonin in affective control. Annu Rev Neurosci. 2009;32:95-126. doi: 10.1146/annurev.neuro.051508.135607. Review.</citation>
    <PMID>19400722</PMID>
  </reference>
  <reference>
    <citation>Palminteri S, Clair AH, Mallet L, Pessiglione M. Similar improvement of reward and punishment learning by serotonin reuptake inhibitors in obsessive-compulsive disorder. Biol Psychiatry. 2012 Aug 1;72(3):244-50. doi: 10.1016/j.biopsych.2011.12.028. Epub 2012 Feb 10.</citation>
    <PMID>22325972</PMID>
  </reference>
  <reference>
    <citation>Pelloux Y, Dilleen R, Economidou D, Theobald D, Everitt BJ. Reduced forebrain serotonin transmission is causally involved in the development of compulsive cocaine seeking in rats. Neuropsychopharmacology. 2012 Oct;37(11):2505-14. doi: 10.1038/npp.2012.111. Epub 2012 Jul 4.</citation>
    <PMID>22763621</PMID>
  </reference>
  <reference>
    <citation>Groman SM, James AS, Seu E, Crawford MA, Harpster SN, Jentsch JD. Monoamine levels within the orbitofrontal cortex and putamen interact to predict reversal learning performance. Biol Psychiatry. 2013 Apr 15;73(8):756-62. doi: 10.1016/j.biopsych.2012.12.002. Epub 2013 Jan 16.</citation>
    <PMID>23332512</PMID>
  </reference>
  <reference>
    <citation>Worbe Y, Palminteri S, Savulich G, Daw ND, Fernandez-Egea E, Robbins TW, Voon V. Valence-dependent influence of serotonin depletion on model-based choice strategy. Mol Psychiatry. 2016 May;21(5):624-9. doi: 10.1038/mp.2015.46. Epub 2015 Apr 14.</citation>
    <PMID>25869808</PMID>
  </reference>
  <reference>
    <citation>el Mansari M, Bouchard C, Blier P. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder. Neuropsychopharmacology. 1995 Oct;13(2):117-27.</citation>
    <PMID>8597523</PMID>
  </reference>
  <reference>
    <citation>Lissemore JI, Sookman D, Gravel P, Berney A, Barsoum A, Diksic M, Nordahl TE, Pinard G, Sibon I, Cottraux J, Leyton M, Benkelfat C. Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline. Transl Psychiatry. 2018 Apr 18;8(1):82. doi: 10.1038/s41398-018-0128-4.</citation>
    <PMID>29666372</PMID>
  </reference>
  <reference>
    <citation>Banca P, Voon V, Vestergaard MD, Philipiak G, Almeida I, Pocinho F, Relvas J, Castelo-Branco M. Imbalance in habitual versus goal directed neural systems during symptom provocation in obsessive-compulsive disorder. Brain. 2015 Mar;138(Pt 3):798-811. doi: 10.1093/brain/awu379. Epub 2015 Jan 6.</citation>
    <PMID>25567322</PMID>
  </reference>
  <reference>
    <citation>Gillan CM, Papmeyer M, Morein-Zamir S, Sahakian BJ, Fineberg NA, Robbins TW, de Wit S. Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. Am J Psychiatry. 2011 Jul;168(7):718-26. doi: 10.1176/appi.ajp.2011.10071062. Epub 2011 May 15.</citation>
    <PMID>21572165</PMID>
  </reference>
  <reference>
    <citation>Apergis-Schoute AM, Gillan CM, Fineberg NA, Fernandez-Egea E, Sahakian BJ, Robbins TW. Neural basis of impaired safety signaling in Obsessive Compulsive Disorder. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3216-3221. doi: 10.1073/pnas.1609194114. Epub 2017 Mar 6.</citation>
    <PMID>28265059</PMID>
  </reference>
  <reference>
    <citation>Chamberlain SR, Fineberg NA, Blackwell AD, Robbins TW, Sahakian BJ. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry. 2006 Jul;163(7):1282-4.</citation>
    <PMID>16816237</PMID>
  </reference>
  <reference>
    <citation>Chamberlain SR, Fineberg NA, Menzies LA, Blackwell AD, Bullmore ET, Robbins TW, Sahakian BJ. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007 Feb;164(2):335-8.</citation>
    <PMID>17267798</PMID>
  </reference>
  <reference>
    <citation>Vaghi MM, VÃ©rtes PE, Kitzbichler MG, Apergis-Schoute AM, van der Flier FE, Fineberg NA, Sule A, Zaman R, Voon V, Kundu P, Bullmore ET, Robbins TW. Specific Frontostriatal Circuits for Impaired Cognitive Flexibility and Goal-Directed Planning in Obsessive-Compulsive Disorder: Evidence From Resting-State Functional Connectivity. Biol Psychiatry. 2017 Apr 15;81(8):708-717. doi: 10.1016/j.biopsych.2016.08.009. Epub 2016 Aug 11.</citation>
    <PMID>27769568</PMID>
  </reference>
  <reference>
    <citation>Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry. 1989 Nov;46(11):1012-6.</citation>
    <PMID>2510699</PMID>
  </reference>
  <reference>
    <citation>Haahr ME, Fisher PM, Jensen CG, Frokjaer VG, Mahon BM, Madsen K, BaarÃ© WF, Lehel S, Norremolle A, Rabiner EA, Knudsen GM. Central 5-HT4 receptor binding as biomarker of serotonergic tonus in humans: a [11C]SB207145 PET study. Mol Psychiatry. 2014 Apr;19(4):427-32. doi: 10.1038/mp.2013.147. Epub 2013 Nov 5.</citation>
    <PMID>24189342</PMID>
  </reference>
  <reference>
    <citation>Foa, E. B. et al. The validation of a new obsessive-compulsive disorder scale: The obsessive-compulsive inventory. Psychological Assessment 10(3), 206-214, 1998.</citation>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 25, 2020</study_first_submitted>
  <study_first_submitted_qc>April 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 7, 2020</study_first_posted>
  <last_update_submitted>April 3, 2020</last_update_submitted>
  <last_update_submitted_qc>April 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Gitte Moos Knudsen</investigator_full_name>
    <investigator_title>Professor, MD, DMSc</investigator_title>
  </responsible_party>
  <keyword>Serotonin</keyword>
  <keyword>Cognition</keyword>
  <keyword>Emotion</keyword>
  <keyword>Neural Activation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
    <mesh_term>Compulsive Behavior</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexetimide</mesh_term>
    <mesh_term>Citalopram</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Upon completion of the study all data will be uploaded to the existing Center for Integrated Molecular Brain Imaging (CIMBI) Database. Researchers may apply for access to the data.</ipd_description>
    <ipd_time_frame>Upon completion of the study.</ipd_time_frame>
    <ipd_access_criteria>Researchers may apply for access to the data.</ipd_access_criteria>
    <ipd_url>https://www.cimbi.dk/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

